PureCleanse™ Antimicrobial Wound Solution

Status: Out of Stock

Case 24 (1)
CA$431.76

 

PureCleanse™ offers a safe and non-cytotoxic, yet powerful antimicrobial cleansing solution for wounds, skin, and burns. 

With no contraindications for use, hypochlorous acid solutions do not damage healthy cells and tissue as they cleanse and debride the wound bed in preparation for healing.1-4

As a pure hypochlorous solution, PureCleanse™ is indicated for the treatment of stage I-IV pressure ulcers, venous insufficiency ulcers, diabetic ulcers, post-surgical wounds, first and second degree burns and minor abrasions.5

Benefits

  • Ideal for preparing the wound bed for healing in a safe, effective and natural way
  • Removal of microorganisms
  • Physical disruption of biofilm
  • Safe, effective debridement irrigation
  • Non-cytotoxic, no-rinse, and sting-free formula
  • Contains no sodium hypochlorite
  • Highly pure and stable solution
  • pH is maintained with high stability mimicking the body's optimal pH level to optimize the healing environment

Optimal Irrigation Pressure

  • 118 mL bottle with Dispensing Cap: 8-12 PSI
  • 250 mL bottle with Dispensing Cap: 8-14 PSI

Powerful Efficiacy

BIHOCL™ hypochlorous acid (HOCl) technology is based on the body’s innate cellular response to infection and is highly effective against bacteria, antibiotic-resistant strains, viruses, fungi, yeasts, and prions.⁶

Groundbreaking Safety

Non-cytotoxic, non-mutagenic, hypoallergenic, non-pyrogenic, endotoxin-free and does not require rinsing.⁶ A unique balance between a powerful antimicrobial and the gentleness of saline.

Simple, Innovative Application

Designed with healthcare providers and patients in mind, our easy-to-use irrigation attachments, optimized for solution delivery, provide effective wound bed debridement.⁶

 

More Info

More Info

Indications

Under the supervision of health care professionals, BIHOCL™ PureCleanse™ is indicated for the cleansing, irrigating, moistening, debridement and removal of foreign material, including microorganisms and debris, from exudating and/or dirty wounds and acute or chronic dermal lesions such as:

  • Stage I-IV pressure ulcers
  • Stasis ulcers
  • Diabetic ulcers
  • Post-surgical wounds
  • First and second degree burns
  • Abrasions
  • Minor irritations of the skin
  • Ingrown toe nails
  • Grafted and donor sites
  • Exit sites

BIHOCL™ PureCleanse™ is also intended for the moistening and lubricating of absorbent wound dressings.

 

Ingredients

  • Water
  • Sodium chloride (NaCl)
  • Pure hypochlorous acid (HOCl) — 0.033%

PureCleanse™ contains no buffers, stabilizers, or additives—just pure, stable hypochlorous acid.

 

Directions

Apply liberally to irrigate and debride wounds and peri-wound tissue. To moisten a dressing, apply to the wound dressing and cover the wound bed. To keep dressing moist, apply solution as prescribed throughout the day.

 

Shelf Life

PureCleanse™ is an highly pure and stable product, providing it with a sealed shelf life of two (2) years. Once the product is opened, any remaining solution should be discarded after 30 days.

 

References

  1. Jenner AM, Ruiz-Rodado E, Dunster C, Halliwell B, Mann GE, Siow RCM. Vitamin C protects against hypochlorous acid–induced glutathione depletion and DNA base and protein damage in human vascular smooth muscle cells. Biochem J. 2007 Feb 1;403(2):433–441.
  2. Winterbourn CC, Brennan SO. Characterization of the oxidation products of the reaction between reduced glutathione and hypochlorous acid. Biochem J. 1997;326(Pt 1):87–92.
  3. Li JX, Pang YZ, Tang CS, Li ZQ. Protective effect of taurine on hypochlorous acid toxicity to nuclear nucleoside triphosphatase in isolated nuclei from rat liver. World J Gastroenterol. 2004;10(5):694–698.
  4. Kearns S, Dawson R Jr. Cytoprotective effect of taurine against hypochlorous acid toxicity to PC12 cells. Adv Exp Med Biol. 2000;483:563–70.
  5. Sterasure Inc. Data on file.
  6. Williams J, Rasmussen E, Robins L, Varela C, Terry D, Harding K (forward). The Handbook of HOCl. 2021.

 

To top